News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
445,118 Results
Type
Article (31685)
Company Profile (43)
Press Release (413386)
Multimedia
Podcasts (117)
Webinars (16)
Section
Business (139073)
Career Advice (1559)
Deals (22466)
Drug Delivery (97)
Drug Development (49342)
Employer Resources (101)
FDA (10551)
Job Trends (10486)
News (224989)
Policy (21010)
Tag
Academia (1854)
Academic (1)
Accelerated approval (10)
Adcomms (14)
Allergies (87)
Alliances (37867)
ALS (102)
Alzheimer's disease (1156)
Antibody-drug conjugate (ADC) (186)
Approvals (10669)
Artificial intelligence (355)
Autoimmune disease (54)
Automation (22)
Bankruptcy (192)
Best Places to Work (8425)
BIOSECURE Act (20)
Biosimilars (130)
Biotechnology (35)
Bladder cancer (100)
Brain cancer (31)
Breast cancer (352)
Cancer (2822)
Cardiovascular disease (249)
Career advice (1343)
Career pathing (29)
CAR-T (133)
CDC (35)
Cell therapy (443)
Cervical cancer (23)
Clinical research (41313)
Collaboration (1134)
Compensation (229)
Complete response letters (27)
COVID-19 (1851)
CRISPR (61)
C-suite (395)
Cystic fibrosis (106)
Data (3313)
Decentralized trials (2)
Denatured (35)
Depression (76)
Diabetes (339)
Diagnostics (4368)
Digital health (28)
Diversity (6)
Diversity, equity & inclusion (31)
Drug discovery (164)
Drug pricing (130)
Drug shortages (27)
Duchenne muscular dystrophy (139)
Earnings (61405)
Editorial (46)
Employer branding (12)
Employer resources (90)
Events (63659)
Executive appointments (683)
FDA (12298)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (2)
Frontotemporal dementia (12)
Funding (892)
Gene editing (125)
Generative AI (40)
Gene therapy (383)
GLP-1 (718)
Government (3126)
Grass and pollen (5)
Guidances (308)
Healthcare (12449)
HIV (40)
Huntington's disease (25)
IgA nephropathy (50)
Immunology and inflammation (175)
Immuno-oncology (14)
Indications (43)
Infectious disease (2007)
Inflammatory bowel disease (135)
Inflation Reduction Act (12)
Influenza (58)
Intellectual property (133)
Interviews (279)
IPO (9743)
IRA (43)
Job creations (2394)
Job search strategy (1107)
Kidney cancer (9)
Labor market (50)
Layoffs (384)
Leadership (28)
Legal (5573)
Liver cancer (55)
Longevity (12)
Lung cancer (422)
Lymphoma (193)
Machine learning (23)
Management (36)
Manufacturing (475)
MASH (111)
Medical device (8245)
Medtech (8262)
Mergers & acquisitions (13352)
Metabolic disorders (862)
Multiple sclerosis (103)
NASH (14)
Neurodegenerative disease (145)
Neuropsychiatric disorders (42)
Neuroscience (1885)
NextGen: Class of 2025 (4419)
Non-profit (3965)
Now hiring (13)
Obesity (413)
Opinion (226)
Ovarian cancer (79)
Pain (114)
Pancreatic cancer (111)
Parkinson's disease (168)
Partnered (22)
Patents (284)
Patient recruitment (175)
Peanut (37)
People (36063)
Pharmaceutical (12)
Pharmacy benefit managers (21)
Phase I (12302)
Phase II (17667)
Phase III (14714)
Pipeline (2303)
Policy (213)
Postmarket research (1863)
Preclinical (5352)
Press Release (41)
Prostate cancer (173)
Psychedelics (33)
Radiopharmaceuticals (183)
Rare diseases (471)
Real estate (3471)
Recruiting (38)
Regulatory (14651)
Reports (37)
Research institute (1712)
Resumes & cover letters (236)
Rett syndrome (11)
RNA editing (11)
RSV (55)
Schizophrenia (102)
Series A (153)
Series B (106)
Service/supplier (5)
Sickle cell disease (62)
Special edition (18)
Spinal muscular atrophy (125)
Sponsored (27)
Startups (2314)
State (1)
Stomach cancer (13)
Supply chain (65)
Tariffs (87)
The Weekly (80)
Vaccines (720)
Venture capital (54)
Weight loss (293)
Women's health (36)
Worklife (13)
Date
Today (99)
Last 7 days (530)
Last 30 days (1831)
Last 365 days (22201)
2025 (17822)
2024 (23822)
2023 (25986)
2022 (33958)
2021 (35304)
2020 (34465)
2019 (31302)
2018 (23658)
2017 (21572)
2016 (21037)
2015 (23683)
2014 (19405)
2013 (16702)
2012 (16854)
2011 (16391)
2010 (15032)
Location
Africa (647)
Alabama (56)
Alaska (6)
Arizona (124)
Arkansas (7)
Asia (26475)
Australia (4249)
California (5889)
Canada (1869)
China (602)
Colorado (272)
Connecticut (304)
Delaware (177)
Europe (61319)
Florida (983)
Georgia (229)
Idaho (34)
Illinois (480)
India (38)
Indiana (329)
Iowa (11)
Japan (248)
Kansas (75)
Kentucky (20)
Louisiana (10)
Maine (31)
Maryland (790)
Massachusetts (4493)
Michigan (232)
Minnesota (288)
Mississippi (2)
Missouri (73)
Montana (18)
Nebraska (13)
Nevada (75)
New Hampshire (44)
New Jersey (1892)
New Mexico (16)
New York (1750)
North Carolina (883)
North Dakota (7)
Northern California (2727)
Ohio (168)
Oklahoma (16)
Oregon (21)
Pennsylvania (1287)
Puerto Rico (3)
Rhode Island (29)
South America (872)
South Carolina (28)
South Dakota (1)
Southern California (2289)
Tennessee (111)
Texas (909)
United States (22330)
Utah (191)
Virginia (131)
Washington D.C. (67)
Washington State (489)
West Virginia (3)
Wisconsin (54)
Wyoming (1)
445,118 Results for "bill and melinda gates foundation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Dr. Patrice Matchaba Appointed as Chief Executive Officer of the Bill & Melinda Gates Medical Research Institute
The Bill & Melinda Gates Medical Research Institute announced the appointment of Patrice Matchaba, MD, as Chief Executive Officer, starting June 10, 2024.
May 28, 2024
·
3 min read
Press Releases
PopVax Announces 1.15 Million USD in Funding from the Bill & Melinda Gates Foundation for Thermostable mRNA Delivery Formulation Development
October 30, 2024
·
3 min read
BIOSECURE Act
The BIOSECURE Act Is Back, as Congress Tacks New Version On to Broader Defense Bill
A new version of the controversial bill removes the specific company names that were included in a previous iteration but still requires the industry to ditch Chinese biotech contractors in order to receive federal dollars.
October 10, 2025
·
1 min read
·
Annalee Armstrong
Press Releases
Immorna Receives Grant from Bill & Melinda Gates Foundation to Support Its mRNA RSV Vaccine Clinical Development
August 26, 2024
·
4 min read
Amidst Ongoing Global Crises, Gates Foundation Announces Largest Annual Budget Ever: $8.6 Billion in 2024 to Save and Improve Lives
The Bill & Melinda Gates Foundation announced its largest annual budget to date as it works toward the goal of a healthier, more prosperous world for all.
January 15, 2024
·
7 min read
Collaboration
Eli Lilly Commits $856M in Biobucks to Gate Bioscience for New Class of Medicines
The collaboration focuses on ‘molecular gates,’ a class of molecules that the startup company Gate Bioscience says can stop pathogenic proteins from leaving the cell.
July 25, 2025
·
1 min read
·
Dan Samorodnitsky
Bill & Melinda Gates Foundation Announces Additional Support to Promote Locally Led R&D; Calls for Proposals
The Bill & Melinda Gates Foundation announced a series of initiatives and a call for proposals to advance locally-led innovation that supports work by scientists and researchers in developing economies.
October 24, 2022
·
4 min read
Drug pricing
Senate Republicans Drop Orphan Drug Exemptions From ‘One Big Beautiful Bill’
The new version of the bill will still need to go through the entire House and Senate.
June 18, 2025
·
2 min read
·
Tristan Manalac
Press Releases
AHF Commends Gov. Newsom for Signing PBM Reform Bill (SB 41, Weiner)
October 13, 2025
·
1 min read
BioCapital
Novavax Announces Agreement with Bill & Melinda Gates Medical Research Institute to Include Matrix-M™ Adjuvant as Potential Component in Vaccine Research
Novavax, Inc., a global company advancing protein-based vaccines with its novel Matrix-M™ adjuvant, has signed a three-year agreement with the Bill & Melinda Gates Medical Research Institute to provide its adjuvant for use in preclinical vaccine research.
June 5, 2023
·
4 min read
1 of 44,512
Next
